Researchers in the Lung Cancer Center at The Valley Hospital's Daniel and Gloria Blumenthal Cancer Center presented their lung cancer research at the prestigious American Association for Thoracic Surgery annual meeting in Philadelphia, PA in May.
This laboratory research is aimed at finding a blood marker for lung cancer, which would greatly assist in the early diagnosis of lung cancer. Lung cancer is only curable in its earliest stages, making early detection of paramount importance.
Robert J. Korst, M.D., Medical Director of The Blumenthal Cancer Center and Director of Thoracic Surgery at The Valley Hospital, has been asked by the American College of Chest Physicians (ACCP) to be a contributor to the third edition of the Evidence-Based Clinical Guidelines for Lung Cancer.
In recognition of the importance of lung cancer in the population and with the rise of evidence-based medicine as a basis for diagnosing the disease and managing those afflicted, the American College of Chest Physicians, through its Health and Science Policy Committee, commissioned the development of evidence-based guidelines on the diagnosis and management of lung cancer. The goal is to assist physicians in achieving the best possible outcomes given the knowledge and capabilities available.
The ACCP Evidence-Based Clinical Guidelines for Lung Cancer, published as a supplement in the journal Chest, and available on the ACCP website, are a series of articles on the diagnosis and management of lung cancer, with specific recommendations based on the quality of published evidence. These guidelines are widely utilized worldwide by practicing physicians dealing with this deadly disease.
